|
(Click here to Order Proceedings)
What do you get when you combine an
at-capacity session room, sold-out exhibits and workshops, and a sold-out
poster session? Another successful meeting from
Cambridge Healthtech
Institute's Biomarkers Series.
Over 300 thought leaders gathered in
Philadelphia on May 3-5, 2004, to discuss the implementation
strategies and issues around
Biomarker Validation and Cancer Biomarkers.
The level of energy and participation reflected
the booming interest in this evolving field. CHI would like to thank the scientific advisors, sponsors, and all of the
participants for making this meeting another success!
Missed
the conference?
While we can't make up for the missed networking
opportunities, we can offer you access to a complete set of conference proceedings, including over 30 speaker
presentations for three full days of sessions. (click here to view the
agenda); a complete set of posters; and summaries of ThinkTank
sessions. Only $400.
Click here
to subscribe
Feedback from the Delegates
"CHI has ones again
done an excellent job of
organizing a biomarker conference with great speakers,
informativetechnology showcase, and enlightening THINK-TANK session.CHI
provided a great networking opportunity for the biomarker scientific
community" |
|
Dr. Mohan B., Project Leader,
Human Biomarker Ctr. GlaxoSmithKline |
|
|
"Well organized meeting. Good forum
for
debate on critical issues involving biomarkers, proteomics, & related areas" |
|
Dr. John
M.,
Principle Scientist, Drug
Discovery Johnson & Johnson
Pharmaceutical R&D
|
|
|
| "If you
came to this meeting and did not learn anything, you were not
listening. If you did learn something, share these ideas with
your colleagues and further develop your understanding through the
opportunity to network" |
|
Dr.
Larry M., Director, Scientific
Affairs
Quest
Diagnostics |
|
|
"Very interesting and stimulating meeting.
Excellent collection of most important topics
in the biomarker
field" |
|
Dr. Barbara V., Senior
Scientist
Pharmacia Pfizer
Group |
|
|
"It is very exciting to see a conference such as
this one fully dedicated to the issues concerning Biomarkers. Personalized
medicine will be the way of the future and
"biomarkers" are the gates towards
that" |
|
Dr. Tedros B.,Research Officer
Biosystems National
Research Council of Canada |
| "Unlike most other
scientific conferences, this conferenceaddressed challenges and
limitations, as well as promisesand advantages, of utilizing biomarkers in
improving diagnosis and treatment of disease" |
|
Dr.
Min S., Program Director, Cancer
Treatment Division National
Cancer
Institute, NIH
|
|
| "Excellent meeting that
brought together stake holders in preclinical and clinical drug
development, pharmacodiagnosticsand clinical validation" |
|
Dr. Tony A., Sub Team Leader,
Preclinial & Clinical Dev Sci
Biogen Idec, Inc. |
|
| "A great gathering of
highly interested and motivated researchers in this growing
area" |
|
Mr. Michael R., Director of Business
Development Intrinsic Bioprobes
|
|
| "The validity of a meeting such as this is
measured by it's attendance, persistence and usefulness. Like all good validation exercises it should be
repeated
often" |
|
Dr. Timothy W., Clinical Scientist, Clin & Exp
Pharmacology, Paterson Institute of Cancer
Research |
|
Photo
Gallery
Over 300 senior
delegates filled the
session room to
capacity.
The ThinkTank session
provided a
small-circle forum for
eight concurrent
discussions, led by expert
facilitators.
Order conference proceedings to
access the
discussion summaries.
The sold-out poster session
provided
added scientific content and fostered
extended networking opportunities.
The lunch technology
workshop
showcased the latest technologies,
while
enjoying the hotel's fine cuisine.
Over 300 delegates viewed
the latest
technologies showcased in the sold-out
exhibit hall.
|
